StockpollyBeta
Get App

Categories·Healthcare·Pharmaceuticals

Prescription Drugs

Medicines that can only be purchased with a doctor's prescription.

−0.11% today·87 stocks

Stocks

By market cap · 87 stocks

  1. 1LLYEli LillyDeveloper of Mounjaro, Zepbound, and Foundayo$1.10T−0.05%
  2. 2JNJJohnson & JohnsonDeveloper of medicines and procedure-based medical technologies$649.40B−0.85%
  3. 3MRKMerckMaker of Keytruda, vaccines, and animal medicines$369.24B+1.04%
  4. 4NVSNovartis (ADR)Developer of focused innovative medicines$267.96B+0.06%
  5. 5AZNAstraZeneca (ADR)Oncology-led developer of specialty medicines$260.70B−0.11%
  6. 6NVONovo Nordisk (ADR)GLP-1 and insulin specialist$176.83B−0.26%
  7. 7PFEPfizerDeveloper of Eliquis, Prevnar and cancer medicines$158.10B+0.20%
  8. 8VRTXVertex PharmaceuticalsDeveloper of CFTR modulators and specialty medicines$129.62B+0.84%
  9. 9MCKMcKessonPharmaceutical distributor and specialty-care services provider$103.79B−0.26%
  10. 10GSKGSK (ADR)Developer of Shingrix, Nucala, and Trelegy$102.34B−1.08%
  11. 11SNYSanofi (ADR)Developer of Dupixent-led medicines and vaccines$102.05B−0.59%
  12. 12REGNRegeneronMaker of Dupixent, EYLEA HD, and Libtayo$82.23B−0.33%
  13. 13CORCencoraGlobal pharmaceutical distribution and specialty-care services$61.58B−0.72%
  14. 14TAKTakeda (ADR)Developer of ENTYVIO and plasma-derived therapies$60.11B+0.13%
  15. 15TEVATeva (ADR)Maker of global generics and neuroscience medicines$46.66B−0.60%
  16. 16RPRXRoyalty PharmaBuyer and funder of drug royalties$25.90B−0.60%
  17. 17VTRSViatrisGlobal maker of established brands and generics$19.91B−0.09%
  18. 18ASNDAscendis Pharma (ADR)TransCon medicines for rare endocrine disorders$14.76B+0.28%
  19. 19CORTCorcept TherapeuticsCortisol-modulation medicines for endocrine disease and cancer$12.30B+1.75%
  20. 20RDYDr. Reddy's Laboratories (ADR)Maker of global generics and pharmaceutical ingredients$10.33B+1.49%
  21. 21ALKSAlkermesNeuroscience medicines for addiction, psychiatry and sleep$7.41B−1.04%
  22. 22AMRXAmneal PharmaceuticalsManufacturer of generics, biosimilars, and specialty medicines$6.44B−3.22%
  23. 23LQDALiquidiaInhaled treprostinil specialist for pulmonary hypertension$5.91B+1.58%
  24. 24DFTXDefinium TherapeuticsDeveloper of lysergide and R(-)-MDMA medicines$5.21B−0.47%
  25. 25INDVIndiviorDeveloper of SUBLOCADE opioid-use-disorder treatment$4.43B+1.67%
  26. 26OGNOrganonWomen's health, biosimilars, and established medicines$3.59B+0.11%
  27. 27TARSTarsus PharmaceuticalsMaker of XDEMVY for Demodex blepharitis$3.33B+0.18%
  28. 28HCMHUTCHMED (ADR)Targeted cancer and immunology medicines$2.53B−2.24%
  29. 29SUPNSupernus PharmaceuticalsDeveloper of ADHD, Parkinson’s, and postpartum depression medicines$2.48B+1.66%
  30. 30TRVITrevi TherapeuticsHaduvio developer targeting chronic cough$2.11B+0.67%
  31. 31ANIPANI PharmaceuticalsMaker of Cortrophin and niche generic drugs$1.79B−1.47%
  32. 32ETONEton PharmaceuticalsRare-disease therapy developer and commercializer$1.52B+2.11%
  33. 33OMEROmerosComplement drug developer with YARTEMLEA launch$1.34B+7.79%
  34. 34LTGOLatigo BiotherapeuticsDeveloper of non-opioid NaV1.8 pain medicines$1.27B−4.52%
  35. 35HROWHarrowOphthalmic medicines and compounding$1.26B−0.29%
  36. 36OPKOPKO HealthBioReference diagnostics and biopharma operator$1.26B+1.78%
  37. 37MNKDMannKindInhaled insulin and cardiometabolic therapies$1.12B−4.17%
  38. 38AMPHAmphastar PharmaceuticalsMaker of complex generic and branded injectable drugs$1.08B−0.68%
  39. 39GYREGyre TherapeuticsMaker of ETUARY, China's lung-fibrosis therapy$828.4M+1.62%
  40. 40ACHVAchieve Life SciencesDeveloper of cytisinicline for nicotine dependence$826.4M+2.38%
  41. 41COLLCollegium PharmaceuticalADHD and pain medicines portfolio$747.3M+0.56%
  42. 42ZVRAZevra TherapeuticsDeveloper of rare-disease treatments for NPC and UCD$689.9M−0.97%
  43. 43AQSTAquestive TherapeuticsPharmFilm developer for rescue medicines$599.7M+3.09%
  44. 44RLMDRelmada TherapeuticsDeveloper of bladder cancer and CNS therapies$436.3M+0.60%
  45. 45EYPTEyePointRetinal drug-delivery therapy developer$337.0M+2.68%
  46. 46CUVLClinuvel Pharmaceuticals (ADR)SCENESSE®-centered melanocortin drug developer$292.5M+1.51%
  47. 47DBVTDBV Technologies (ADR)Developer of the Viaskin Peanut Patch$289.5M−1.40%
  48. 48AMRNAmarin (ADR)Commercializer of Vascepa cardiovascular therapy$278.8M+1.85%
  49. 49ANIKAnika TherapeuticsHA orthopedics for OA pain$277.0M+0.97%
  50. 50SIGASIGASmallpox antiviral for government stockpiles$226.6M+1.42%